Lista de obras -

Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia

artículo científico publicado en 2017

Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy

artículo científico publicado en 2017

Different Faces of Neurosyphilis

scientific article published on 01 July 2018

Diverse clinical presentations of neurosyphilis: focus on differential diagnosis.

artículo científico publicado en 2017

Efficacy of Ketamine in bipolar depression: focus on anhedonia

artículo científico publicado en 2019

Lithium therapeutic dose monitoring in human saliva

artículo científico publicado en 2017

Magnesium and ketamine in the treatment of depression

artículo científico publicado en 2019

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

artículo científico publicado en 2020

Neurosyphilis - the white matter disintegration? - two case reports

artículo científico publicado en 2017

Neurosyphilis presenting with cognitive deficits - a report of two cases

artículo científico publicado en 2017

Neurosyphilis: a masked evildoer

artículo científico publicado en 2018

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

artículo científico publicado en 2017

Role of copper and ketamine in major depressive disorder - an update

artículo científico publicado en 2019

Short-term ketamine administration in treatment-resistant depression patients: focus on adverse effects on the central nervous system

artículo científico publicado en 2019

Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety

artículo científico publicado en 2019

Suicidality in treatment resistant depression: perspective for ketamine use

artículo científico publicado en 2019

Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities

artículo científico publicado en 2017

The Role of Hormones and Inflammatory Markers in Cognitive Functioning of Schizophrenic Patients

artículo científico publicado en 2017

The immunomodulatory effect of ketamine in depression

artículo científico publicado en 2019

What really is a 'gold standard' in depression recognition among patients with epilepsy?

scientific article published on 19 July 2018

Lista de obras de

Benzodiazepines as adjunctive therapy in treatment refractory symptoms of schizophrenia

Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy

Different Faces of Neurosyphilis

Diverse clinical presentations of neurosyphilis: focus on differential diagnosis.

Efficacy of Ketamine in bipolar depression: focus on anhedonia

Lithium therapeutic dose monitoring in human saliva

Magnesium and ketamine in the treatment of depression

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Neurosyphilis - the white matter disintegration? - two case reports

Neurosyphilis presenting with cognitive deficits - a report of two cases

Neurosyphilis: a masked evildoer

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration first episode major depressive disorder: An exploratory study.

Role of copper and ketamine in major depressive disorder - an update

Short-term ketamine administration in treatment-resistant depression patients: focus on adverse effects on the central nervous system

Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety

Suicidality in treatment resistant depression: perspective for ketamine use

Telepsychiatry and Virtual Reality an the Teatment of Patients with Intellectual and Developmental Disabilities

The Role of Hormones and Inflammatory Markers in Cognitive Functioning of Schizophrenic Patients

The immunomodulatory effect of ketamine in depression

What really is a 'gold standard' in depression recognition among patients with epilepsy?